2/ The early 2000s discovery of IL-23 and IL-23R was associated with the characterization of TH17 cells as distinct T-cell lineage, different from TH1 / TH2 cells (nature.com/articles/natur…).
3/ In this paradigm, IL-12 is the IFN--inducing signature cytokine, whereas IL-23 is the IL-17-inducing signature cytokine (nature.com/articles/nm.38…).
4/ However, in 2018, we reported two siblings with inherited IL-23R deficiency and surprisingly, mycobacterial disease in @SciImmunology (science.org/doi/10.1126/sc…).
5/ In the same issue of @SciImmunology, we reported that homozygosity for P1104A TYK2 selectively impairs cellular responses to IL-23 and underlies mycobacterial disease (science.org/doi/10.1126/sc…).
6/ These findings paradoxically suggested that contrary to the IL-12/TH1 and IL-23/TH17 paradigm, human IL-23 is required for optimal IFN--dependent immunity to mycobacteria, but redundant for optimal IL-17-dependent immunity to C. albicans (science.org/doi/10.1126/sc…).
7/ Here, in @ SciImmunology again, (science.org/doi/10.1126/sc…) we report an in-depth molecular, immunological, and clinical analysis of six patients from four kindreds with IL-23R deficiency. All of them had mycobacterial disease, while only two had mild candidiasis.
8/ We show that the development of C. albicans–specific memory CD4+ T cells is preserved in IL-23R–deficient patients and that IL-23 induces IL-17A only in MAIT cells, possibly accounting for the incomplete penetrance of candidiasis in patients unresponsive to IL-23.
9/ By contrast, IL-23 is required for both baseline and IL-23-inducible IFN- immunity in both V2 T and MAIT cells, likely contributing to the much higher penetrance of mycobacterial disease in these patients.
10/ These findings are consistent with our recent report that impaired IL-23 signaling is the core mechanism of mycobacterial disease in patients with all forms of inherited TYK2 deficiency (doi.org/10.1084/jem.20…).
11/ Overall, our findings suggest that human IL-12 and IL-23 are functionally very closely related, via their induction of IFN-γ.
12/ These findings conflict with the classical TH1/TH17 paradigm established in mice, further suggesting that mouse and human immunology should be reconsidered through the lens of genetics (doi.org/10.1146/annure…).
13/ These findings further suggest that the clinical efficacy of IL-23 blockers may not be related to their impact on IL17 immunity – but rather to its impact on IFN-… (nature.com/articles/nri37…)
1/ We are excited to share some news about human IRF1, which surprisingly turns out to be the key transcription factor downstream from IFN-gamma and STAT1 in macrophages (sciencedirect.com/science/articl…).
3/ IRF1 was characterized as a transcription factor essential for the development of NK and CD8 TR cells, as well as the action of both type I and type II IFNs. It was also the first member of the large family of IRFs (tinyurl.com/y8ntvvsf).
1/ Together with the COVID Human Genetics Effort, we are happy to report our finding of inborn errors of the OAS-RNase L pathway in children with MIS-C #Misc#Pims in @ScienceMagazine (science.org/doi/10.1126/sc…)
1/ We are happy to share with you our paper in @JExpMed reporting auto-Abs to type I IFNs in 5% of patients with critical influenza pneumonia (rupress.org/jem/article/21…; ).
2/ The risk of critical influenza was highest in patients with auto-Abs neutralizing high concentrations of both IFN-alpha2 and IFN-omega (OR=11.7, P=1.3x10-5), especially those <70 yr old (OR=139.9, P=3.1x10-10).
3/ This paper builds on our previous demonstration that auto-Abs to type I IFNs are present in the general population (science.org/doi/10.1126/sc…).
1/ Happy to share a perspective of our 30-year-long journey searching for human genetic and immunological determinants of infectious diseases (sciencedirect.com/science/articl…).
2/ The key question in the field of infectious diseases is paradoxically that of their root cause, as only a small proportion of infected people are severely ill – this is “the infection enigma” (annualreviews.org/doi/abs/10.114…).
3/ We explain how the genetic study of patients, including single patients, with rare infections, led to the discovery of determinants of disease in many patients with related, common infections.
2/ They discovered OTULIN haploinsufficiency via a genome-wide approach in a cohort of patients with unexplained, life-threatening staphylococcal disease – the findings are relevant in vivo.
3/ The clinical hallmark of OTULIN haploinsufficiency is necrosis of the skin and/or lungs, typically triggered by infections with #Staphylococcus aureus.